Six years after her first heart transplant, Tiernee’s body began to reject her donor heart and she developed end-stage kidney failure — her doctors knew they had to act quickly in order to save her life.
When Danny’s heart began to fail, his doctors implanted an LVAD to help improve blood flow. But when a clot formed in the pump six weeks later, his doctors chose to remove the LVAD and implant the SynCardia Total Artificial Heart. Read his story.
When Pat was admitted to Indiana University Health Methodist Hospital, he was facing a dire situation that had become all too familiar for his family. Read Pat’s story on his journey to finding a new heart.
The SynCardia Total Artificial Heart is a life-saving treatment option for patients diagnosed with end-stage heart failure affecting both sides of the heart.
For heart transplant recipients who experience graft failure, chronic allograft vasculopathy or rejection, the TAH overcomes limitations associated with the use of LVADs and BiVADs as a bridge to transplant in this population.